Selected Publications
* corresponding authorship
- Mony, U., Russell, N. and Pallis, M. 2006. Optimization of a 48 hour in vitro chemosensitivity assay for CD34+ CD38- CD123+ leukaemic stem and progenitor cells. Haematologica. vol. 91(s1)-235-236
- Mony, U., Jawad, M., Seedhouse, C., Russell, N. and Pallis, M. 2008. Resistance to FLT3 inhibition in an in vitro model of primary AML cells with a stem cell phenotype in a defined microenvironment. Leukemia. 22: 1395-1401
- Jawad, M., Seedhouse, C., Mony, U., Grundy,M., Russell, N. and Pallis, M. 2010. Analysis of factors that affect In vitro Chemosensitivity of Leukaemic Stem and Progenitor cells to Gemtuzumab Ozogamicin (Mylotarg) in Acute Myeloid Leukaemia . Leukemia 24 (1), 74-80
- Sreeja N, Binulal N S, Mony, U, Manzoor K, Shantikumar Nair and Deepthy Menon. 2010. Polymer Nanoencapsulated, Folate Receptor Targeted Grape Seed Extract for ?Green’ Chemotherapy of Multiple Human Cancers. Nanotechnology 21: 285107
- Binulal, N.S., Menon, D., Nagarajan, S., Shalumon, K.T., Suja, S., Mony, U., Rangaswamy, J. and Nair, S.V. 2010. Role of nano-fibrous poly (caprolactone) scaffolds on human mesenchymal stem cell attachment and spreading for in vitro bone tissue engineering-response to osteogenic regulators. Tissue Engineering A. 16(2): 393-404
- Retnakumari, A., Jayasimhan, J., Menon, D., Nair, S.K., Mony, U* and Koyakutty, M*. 2011. CD33 mAb conjugated Au cluster nano-bioprobes for flow cytometric detection of acute myeloid leukaemia. Nanotechnology. 15;22(28):285102
- Retnakumari AP, Hanumanthu PL, Malarvizhi GL, Prabhu R, Sidharthan N, Thampi MV, Menon D, Mony U, Menon K, Keechilat P, Nair S, Koyakutty M. 2012. Rationally designed dual targeted nanomedicine against oncogene mutated/amplified refractory chronic meyloid leukemia. Molecular Pharmaceutics. 9(11):3062-78
- Ruben, H.A., Shen,L., Mony, U., Peguero, E., Pera, B., and Moore, M.A.S. 2013. Temporal generation and molecular characterization of functional hematopoietic cells from human embryonic stem cells. Blood. Vol 120. No.21-23
- S. Ambati, Eloisi Caldas Lopes, Kohji Kosugi, Mony, U, Ahmet Zehir, Andre Moreira, Paul A. Meyers, Gabriela Chiosis and Malcolm A.S. Moore. 2014. Pre-clinical efficacy of PU-H71, a novel HSP90 inhibitor, alone and in combination with bortezomib in Ewing sarcoma. Molecular Oncology. Mar;8(2):323-36
- Maya, S., Mony, U*. and Jayakumar, R.* 2014. Thermo-responsive fibrinogen nanogels: a viable thermo-responsive drug delivery agent for breast cancer therapy?. Nanomedicine 9(18):2721-3 (Invited Paper).
- Mony, U*. R Hoya-Arias, S Ambati, B Pera, Y Dogan, E Peguero, JH Shieh and M Moore. 2014. Artesunate, an antimalarial drug displays preclinical activity in FLT3 mutated leukemia and synergises with AraC. Haematologica. 99(s1) 35-36
- Narayanan S, Mony U, Vijaykumar DK, Koyakutty M, Paul-Prasanth B, Menon D. 2015. Sequential release of epigallocatechin gallate and paclitaxel from PLGA-casein core/shell nanoparticles sensitizes drug-resistant breast cancer cells. Nanomedicine. 11(6): 1399-406
- Maya S. Nair, Mony, U* et al., 2015. Establishment and Molecular Characterization of a Defined 3-D Niche Condition for in vitro Chemosensitivity Against Acute Myeloid Leukemic Cells Using Polymeric Micro-Nanofibrous Scaffold. International journal of nanomedicine. 15;10:3603-22
- Sathy BN, Mony U, Menon D, Baskaran VK, Mikos AG, Nair S. 2015. Bone Tissue Engineering with Multilayered Scaffolds-Part I: An Approach for Vascularizing Engineered Constructs In Vivo. Tissue Eng Part A 21 (19-20): 2480-94
- Anitha, A., Maya, S., Sivaram, A.J., Mony, U*. and Jayakumar*, R. 2016. Combinatorial nanomedicines for colon cancer therapy. Nanomedicine and Nanobiotechnology. 8(1): 151-9
- Sowmya S, Mony, U, Jayachandran P, Reshma S, Kumar RA, Arzate H, Nair SV and Jayakumar R. 2017. Tri-Layered Nanocomposite Hydrogel Scaffold for the Concurrent Regeneration of Cementum, Periodontal Ligament, and Alveolar Bone. Adv Healthc Mater. 2017 Apr;6(7)
- Satheesh Kumar MK, Nair S, Mony, U, Kalingavarman S, Venkat R, Sivanarayanan TB, Unni AKK, Rajeshkannan R, Anandakuttan A, Radhakrishnan S and Menon KN. 2017. Significance of elevated Prohibitin 1 levels in Multiple Sclerosis patients lymphocytes towards the assessment of subclinical disease activity and its role in the central nervous system pathology of disease. Int J Biol Macromol. Dec 11
- Vignesh S, Gopalakrishnan A, M R P, Nair SV, Jayakumar R and Mony , U. 2018. Fabrication of micropatterned alginate-gelatin and k-carrageenan hydrogels of defined shapes using simple wax mould method as a platform for stem cell/induced Pluripotent Stem Cells (iPSC) culture. Int J Biol Macromol. Feb 7;112:737-744
- Sundaram MN, Amirthalingam S, Mony U, Varma PK, Jayakumar R. 2019. Injectable chitosan-nano bioglass composite hemostatic hydrogel for effective bleeding control. Int J Biol Macromol. 129:936-943
- Sundaram MN, M, Deepthi S, Mony U, Shalumon KT, Chen JP, Jayakumar R. 2019. Chitosan hydrogel scaffold reinforced with twisted poly(l lactic acid) aligned microfibrous bundle to mimic tendon extracellular matrix. Int J Biol Macromol. 122:37-44
- Mony, U., Sanju S., Jain , P., Sugavanan K ., Sebastian, A., Theertha M., Sidharthan, N and Varma, P.K. 2019.. Detection of Dysregulated Host Response By Flow Cytometry May Pre-Empt Early Diagnosis of Sepsis after Cardiac Surgery. Blood. 134 (Supplement-1) : 4863-4865
- Sidharthan N., Fuchs E., Unni M., Mony, U., Boyella P., Prabhu R., Ganapathy R., Shenoy, V and Vidyadharan G. 2019. HLA-mismatched microtransplantation for relapsed or refractory acute myeloid leukemia as a bridge to allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant. Nov 29. doi: 10.1038/s41409-019-0761-4
- Nija R.J, Sanju, S, Sidharthan, N and Mony, U*. 2020. Extracellular Trap by Blood Cells: Clinical Implications. Tissue Eng and Reg. Med. 17(2):141-153
- Sharath SS, Ramu J, Nair SV, Iyer S, and Mony U*, Rangasamy J. 2020. Human Adipose Tissue Derivatives as a Potent Native Biomaterial for Tissue Regenerative Therapies. Tissue Eng and Reg. Med. 17(2):123-140
- Theertha M, Sanju S, Priya VV, Jain P, Varma PK, and Mony U*. 2020. Innate Lymphoid Cells: Potent Early Mediators of the Host Immune Response During Sepsis. Cell Mol Immunol. Mar 4. doi: 10.1038/s41423-020-0383-1
- Nivedhitha, S., Mony, U., Varma, P.K. and Rangasamy J. 2021. Vasoconstrictor and coagulation activator entrapped chitosan based composite hydrogel for rapid bleeding control. Carbohydrate Polymers. 258: 117634
- Deepthi, S., Mony, U * and Rangasamy, J. 2021. Combinatorial effect of plasma treatment, fiber alignment and fiber scale of poly (ε-caprolactone)/collagen multiscale fibers in inducing tenogenesis in non-tenogenic media. Materials Science & Engineering C 127: 112206
- Poorna M R; Sudhindran S; M V Thampi and Mony, U*. 2021. Differentiation of induced pluripotent stem cells to hepatocyte-like cells on cellulose nanofibril substrate. Colloids Surf B Biointerfaces . Volume 198, 111466
- Poorna, M.R, R, Jayakumar, Jyh-Ping Chen, Mony U*. 2021. Hydrogels: A potential platform for induced pluripotent stem cell culture and differentiation. Colloids Surf B Biointerfaces. 207:111991
- Sebastian, A. Sanju, S, Priya, V.V, Varma, P.K, Mony,U*. 2021. Non-classical monocytes and its potential in diagnosing sepsis post cardiac surgery. International Immunopharmacology. 99: 108037
- Nair, A., Nair, S.C., Banerji, A., Biswas, R. and Mony, U.*. 2021. Development and evaluation of plumbagin loaded chitin hydrogel for the treatment of skin cancer. J Drug Deliv Sci Technol. 66: 102804
- Malavika, M., Sanju, S., Poorna, M.R., Priya VV., Sidharthan, N., Varma, P.K. and Mony, U*. 2022. Role of myeloid derived suppressor cells in sepsis. International Immunopharmacology 104:108452
- Sanju, S., Jain, P., Priya, V.V., Varma, P.K. and Mony, U*. 2022. Quantitation of mHLA-DR and nCD64 by Flow Cytometry to study dysregulated host response: The use of QuantiBRITE TM PE beads and its stability. Applied Biochemistry and Biotechnology. 11;1-6
